Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NOD takes its toll but stays in the CARDs in Crohn's disease.

Literature DB >> 16010582

NOD takes its toll but stays in the CARDs in Crohn's disease.

Friedrich C Luft¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2005 PMID： 16010582 DOI： 10.1007/s00109-005-0686-9

Source DB: PubMed Journal: J Mol Med (Berl) ISSN： 0946-2716 Impact factor: 4.599

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. How NOD-ing off leads to Crohn disease.

Authors: Luke A J O'Neill
Journal: Nat Immunol Date: 2004-08 Impact factor: 25.606

2. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.

Authors: Henri Braat; Pieter Stokkers; Tijmen Hommes; Danny Cohn; Esther Vogels; Inge Pronk; Arnold Spek; Antoine van Kampen; Sander van Deventer; Maikel Peppelenbosch; Daan Hommes
Journal: J Mol Med (Berl) Date: 2005-07-12 Impact factor: 4.599

3. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

Authors: Masayuki Fukata; Kathrin S Michelsen; Rajaraman Eri; Lisa S Thomas; Bing Hu; Katie Lukasek; Cynthia C Nast; Juan Lechago; Ruliang Xu; Yoshikazu Naiki; Antoine Soliman; Moshe Arditi; Maria T Abreu
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2005-05 Impact factor: 4.052

4. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

Authors: R Balfour Sartor
Journal: Curr Opin Gastroenterol Date: 2003-07 Impact factor: 3.287

5. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

Authors: David A van Heel; Subrata Ghosh; Matt Butler; Karen A Hunt; Anna M C Lundberg; Tariq Ahmad; Dermot P B McGovern; Clive Onnie; Kenichi Negoro; Sue Goldthorpe; Brian M J Foxwell; Christopher G Mathew; Alastair Forbes; Derek P Jewell; Raymond J Playford
Journal: Lancet Date: 2005 May 21-27 Impact factor: 79.321

NOD takes its toll but stays in the CARDs in Crohn's disease.

1. How NOD-ing off leads to Crohn disease.

2. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.

3. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

4. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

5. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

6. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

7. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition.

8. Role of nod2 in the response of macrophages to toll-like receptor agonists.

9. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

10. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.